We assessed whether polymorphisms in OCT3 were associated with markers of adiposity and insulin resistance and found that OCT3 polymorphisms were associated with adiposity, diabetes status, and circulating lipids, strengthening the link between OCT3 transport and fat accumulation and insulin resistance. This evidence concerns the gene SLC22A3 and diabetes mellitus.